New hope for hard-to-treat bowel cancer: targeted combo shows promise
Disease control
Not yet recruiting
This study tests a new combination of drugs (aipalolitovorelizumab, bevacizumab, and chemotherapy) as a first treatment for people with advanced colorectal cancer that has a specific gene change called BRAF V600E. The goal is to see if this combo shrinks tumors and controls the d…
Phase: PHASE2 • Sponsor: Yanqiao Zhang • Aim: Disease control
Last updated May 15, 2026 11:53 UTC